Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine

[1]  E. Cerasi,et al.  Beta-cell memory to insulin secretagogues: characterization of the time-dependent inhibitory control system in the isolated rat pancreas. , 1989, Endocrinology.

[2]  R. Bergman,et al.  Increased β-Cell Secretory Capacity as Mechanism for Islet Adaptation to Nicotinic Acid-Induced Insulin Resistance , 1989, Diabetes.

[3]  Hj Norussis,et al.  SPSS for Windows , 1993 .

[4]  J. Halter,et al.  Dexamethasone-induced insulin resistance enhances B cell responsiveness to glucose level in normal men. , 1984, The American journal of physiology.

[5]  G. Berglund,et al.  Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance. , 1995, The Journal of clinical endocrinology and metabolism.

[6]  R. Bergman,et al.  Repeatability of Insulin Sensitivity and Glucose Effectiveness From the Minimal Model: Implications for Study Design , 1994, Diabetes.

[7]  B. Ahrén,et al.  Islet dysfunction in obese women with impaired glucose tolerance. , 1996, Metabolism: clinical and experimental.

[8]  J. Halter,et al.  Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for imparied glucose potentiation. , 1979, The Journal of clinical endocrinology and metabolism.

[9]  S. Bardet,et al.  Inter and intra individual variability of acute insulin response during intravenous glucose tolerance tests. , 1989, Diabete & metabolisme.

[10]  V. Grill.  Time and dose dependencies for priming effect of glucose on insulin secretion. , 1981, The American journal of physiology.

[11]  D. Porte.  β-cells in type II diabetes mellitus , 1991, Diabetes.

[12]  R. Bergman,et al.  Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. , 1989, Diabetes.

[13]  T. W. Haeften,et al.  Decreased insulin secretory capacity and normal pancreatic B‐cell glucose sensitivity in non‐obese patients with NIDDM , 1991, European journal of clinical investigation.

[14]  E. Cerasi.  Potentiation of insulin release by glucose in man. , 1975, Acta endocrinologica.

[15]  J. Holst,et al.  Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus. , 1997, The Journal of clinical endocrinology and metabolism.

[16]  R. Bergman,et al.  Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose. , 1990, The Journal of clinical endocrinology and metabolism.

[17]  E. Cerasi,et al.  Potentiation and inhibition of insulin release in man following priming with glucose and with arginine--effect of somatostatin. , 1979, Acta endocrinologica.

[18]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[19]  S. Kahn,et al.  Effect of heparin on insulin-glucose interactions measured by the minimal model technique: implications for reproducibility using this method. , 1993, Metabolism: clinical and experimental.

[20]  L. Harrison,et al.  Reproducibility of the First-Phase Insulin Response to Intravenous Glucose Is Not Improved by Retrograde Cannulation and Arterialization or the Use of a Lower Glucose Dose , 1995, Diabetes Care.

[21]  O. Faber,et al.  Reproducibility of βCell Function Estimates in Non-Insulin-Dependent Diabetes Mellitus , 1987, Diabetes Care.

[22]  A. Scheen,et al.  Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications. , 1996, Diabetes & metabolism.

[23]  J. Halter,et al.  Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. , 1984, The Journal of clinical investigation.

[24]  Marija J. Norusis,et al.  SPSS for Windows Base System User''s Guide , 1992 .